Meeting
2018 ASCO Annual Meeting
Effects of comprehensive genomic testing in a large non-small cell cancer NSCLC cohort: Racial and survival impacts.
Authors
Fatemeh Ardeshir-Larijani
University Hospital Siedman Cancer Center, Case Western Reserve University, Cleveland, OH
Fatemeh Ardeshir-Larijani , Asrar Alahmadi , Pingfu Fu , Gary Wildey , Mary Beth Lipka , Afshin Dowlati
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 36, 2018 (suppl; abstr 8526)
DOI
10.1200/JCO.2018.36.15_suppl.8526
Abstract #
8526
Poster Bd #
132
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
First Author: Shingo Matsumoto
Poster
2020 ASCO Virtual Scientific Program
Establishment of the first international large-scale, genomic screening platform to identify patients with rare oncogene drivers in non-small cell lung cancer (NSCLC) in East Asia.
First Author: Shingo Matsumoto
Poster
2023 ASCO Quality Care Symposium
Real-world treatment patterns and clinical outcomes post standard of care (SOC) among patients (pts) with metastatic non-small cell lung cancer (mNSCLC) with and without actionable genomic alterations (AGAs) in the United States (US).
First Author: Ruchit Shah
Poster
2023 ASCO Annual Meeting
A nation-wide genomic screening project for further development of targeted therapies in treatment-refractory non–small-cell lung cancer (LC-SCRUM-TRY).
First Author: Hiroki Izumi